| Pharmaceutical Manufacturing | Sterile injectables, oncology, ophthalmic products, complex injectables, contract manufacturing and development services. | FDA-approved facilities, in-house API synthesis, extensive regulatory expertise, diversified global customer base, and strong R&D capabilities. | Pharmaceutical companies (B2B) globally, primarily in regulated markets including USA, Europe, Canada, Australia. | Complex oncology injectables, drug-device combinations, and contract manufacturing have highest profit margins. | 5830 | 100 | Sales of generic injectable drugs, contract manufacturing agreements, technology transfer fees, and co-development partnerships. | Contract and sales-based pricing, long-term supply agreements, pricing aligned to regulatory and market standards. | Strong ANDA approvals, capacity expansions, complex product launches, and strategic acquisitions drive revenue growth. | Eribulin, Dexrazoxane, Enoxaparin, Ready-to-Use infusion bags |
